GABAB receptor agonist only reduces ethanol drinking in light-drinking mice

Pharmacology Biochemistry and Behavior

Volumn 102, Issue 2, 2012, Pages 233-240

  Villas Boas, Gustavo Roberto ^a   Zamboni, Camila Gadens ^a   Peretti, Murilo Calvo ^a   Correia, Diego ^a   Rueda, André Veloso Lima ^b   Camarini, Rosana ^b   Brunialti Godard, Ana Lucia ^c   Boerngen Lacerda, Roseli ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Addiction; Baclofen; Ethanol; Free choice paradigm; GABAB receptor; Mice

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; 4 AMINOBUTYRIC ACID B1; 4 AMINOBUTYRIC ACID B2; ALCOHOL; BACLOFEN; QUININE; SODIUM CHLORIDE; UNCLASSIFIED DRUG; WATER;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DOSE RESPONSE; DRINKING BEHAVIOR; FLUID INTAKE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; TREATMENT RESPONSE;

ALCOHOL DRINKING; ANIMALS; BACLOFEN; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING BEHAVIOR; ETHANOL; GABA AGONISTS; MALE; MICE; RECEPTORS, GABA-B;

ANIMALIA; MUS;

EID: 84861220263     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.04.011     Document Type: Article

References (70)

1. Addolorato G, Caputo F, Capristo E, Colombo G, Gessa GL, Gasbarrini G. Ability of baclofen in reducing alcohol craving and intake: II. Preliminary clinical evidence. Alcohol Clin Exp Res 2000;24:67-71.
2. Addolorato G, Caputo F, Capristo E, Janiri L, Bernardi M, Agabio R, et al. Rapid suppression of alcohol withdrawal syndrome by baclofen. Am J Med 2002;112:226-9.
3. Anstrom KK, Cromwell HC, Markowski T, Woodward DJ. Effect of baclofen on alcohol and sucrose self-administration in rats. Alcohol Clin Exp Res 2003;27:900-8.
4. Bechtholt AJ, Cunningham CL. Ethanol-induced conditioned place preference is expressed through a ventral tegmental area dependent mechanism. Behav Neurosci 2005;119:213-23.
5. Boening JAL, Lesch OM, Spanagel R, Wolffgramm J, Narita M, Sinclair D, et al. Pharmacological relapse prevention in alcohol dependence: from animal models to clinical trials. Alcohol Clin Exp Res 2001;25(5 Suppl. ISBRA):127S-31S.
6. Boerngen-Lacerda R, Souza-Formigoni MLO. Does the increase in locomotion induced by ethanol indicate its stimulant or anxiolytic properties? Pharmacol Biochem Behav 2000;67:225-32.
7. Brebner K, Childress AR, Roberts DCS. A potential role for GABAB agonists in the treatment of psychostimulant addiction. Alcohol Alcohol 2002;37:478-84.
8. Brebner K, Ahn S, Phillips AG. Attenuation of D-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates. Psychopharmacology 2005;177:409-17.
9. Callahan PM, de la Garza II R, Cunningham KA. Mediation of the discriminative stimulus properties of cocaine by mesocorticolimbic dopamine systems. Pharmacol Biochem Behav 1997;57:601-7.
10. Camarini R, Pautassi R, Méndez M, Quadros IM, Souza-Formigoni ML, Boerngen- Lacerda R. Behavioral and neurochemical studies in distinct animal models of ethanol's motivational effects. Curr Drug Abuse Rev 2011. Jan 5: [Epub ahead of print].
11. Chang JY, Sawyer SF, Lee RS, Woodward DJ. Electrophysiological and pharmacological evidence for the role of the nucleus accumbens in cocaine self-administration in freely moving rats. J Neurosci 1994;14:1224-44.
12. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP. Limbic activation during cue-induced cocaine craving. Am J Psychiatry 1999;156:11-8.
13. Colombo G, Agabio R, Carai MAM, Lobina C, Pani M, Reali R, et al. Ability of baclofen in reducing alcohol intake and withdrawal severity: I. Preclinical evidence. Alcohol Clin Exp Res 2000;24:58-66.
14. B receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behaviour in alcohol-preferring rats. Alcohol Alcohol 2002;37:499-503.
15. Colombo G, Serra S, Brunetti G, Vacca G, Carai MAM, Gessa GL. Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats. Drug Alcohol Depend 2003a;70:105-8.
16. Colombo G, Vacca G, Serra S, Brunetti G, Carai MAM, Gessa GL. Baclofen suppresses motivation to consume alcohol in rats. Psychopharmacology 2003b;167:221-4.
17. Correia D, Ribeiro AF, Brunialti Godard A, Boerngen-Lacerda R. Trait anxiety and ethanol: anxiolysis in high-anxiety mice and no relation to intake behavior in an addiction model. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:880-8.
18. Crabbe JC, Metten P, Rhodes JS, Yu CH, Brown LL, Phillips TJ, et al. A line of mice selected for high blood ethanol concentrations shows drinking in the dark to intoxication. Biol Psychiatry 2009;65:662-70.
19. B agonist baclofen in rats. Alcohol Clin Exp Res 2006;30:812-8.
20. Everitt BJ, Robbins TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 2005;8:1481-9. [erratum: 9:979].
21. Fachin-Scheit DJ, Ribeiro AF, Pigatto G, Goeldner FO, Boerngen de Lacerda R. Development of a mouse model of ethanol addiction: naltrexone efficacy in reducing consumption but not craving. J Neural Transm 2006;113:1305-21.
22. B receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination. Eur J Pharmacol 2007;574:148-57.
23. Garbutt JC, Kampov-Polevoy AB, Gallop R, Kalka-Juhl L, Flannery BA. Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebocontrolled trial. Alcohol Clin Exp Res 2010;34:1849-57.
24. George MS, Anton RF, Bloomer C, Teneback C, Drobes DJ, Lorberbaum JP, et al. Activation of prefrontal cortex and anterior thalamus in alcoholic subjects on exposure to alcohol-specific cues. Arch Gen Psychiatry 2001;58:345-52.
25. Grant S, London ED, Newlin DB, Villemagne VL, Liu X, Contoreggi C, et al. Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A 1996;93:12040-5.
26. Heilig M, Egli M. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharm Ther 2006;111:855-76.
27. Hopf FW, Chang SJ, Sparta DR, Bowers MS, Bonci A. Motivation for alcohol becomes resistant to quinine adulteration after 3-4 months of intermittent alcohol self-administration. Alcohol Clin Exp Res 2010;34:1565-73.
28. Janak PH, Gill MT. Comparison of the effects of allopregnanolone with direct GABAergic agonists on ethanol self-administration with and without concurrently available sucrose. Alcohol 2003;30:1-7.
29. Johnson BA. Medication treatment of different types of alcoholism. Am J Psychiatry 2010;167:630-9.
30. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005;162:1403-13.
31. Knapp DJ, Overstreet DH, Breese GR. Baclofen blocks expression and sensitization of anxiety-like behavior in an animal model of repeated stress and ethanol withdrawal. Alcohol Clin Exp Res 2007;31:582-95.
32. Koob GF. Animal models of craving for ethanol. Addiction 2000;95(Suppl. 2):s73-81.
33. Koob GF, Bloom FE. Cellular and molecular mechanisms of drug dependence. Science 1988;242:715-23.
34. Koob GF, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 1997;278: 52-8.
35. Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001;24:97-129.
36. Koob GF, Le Moal M. Neurobiology of Addiction. London: Academic Press; 2006.
37. B and dopamine D2 receptors in rat substantia nigra neurones. J Physiol 1988;401:437-53.
38. Lesscher HM, van Kerkhof LW, Vanderschuren LJ. Inflexible and indifferent alcohol drinking in male mice. Alcohol Clin Exp Res 2010;34:1219-25.
39. Liang F, Hatanaka Y, Saito H, Yamamori T, Hashikawa T. Differential expression of γ-aminobutyric acid type B receptor-1a and -1b mRNA variants in GABA and non-GABAergic neurons of the rat brain. J Comp Neurol 2000;416:475-95.
40. Ling W, Shoptaw S, Majewska D. Baclofen as a cocaine anti-craving medication: a preliminary clinical study. Neuropsychopharmacology 1998;18:403-4.
41. Maccioni P, Serra S, Vacca G, Orru A, Pés D, Agabio R, et al. Baclofen-induced reduction of alcohol reinforcement in alcohol-preferring rats. Alcohol 2005;36:161-8.
42. Maccioni P, Bienkowskic P, Carai MAM, Gessa GL, Colombo G. Baclofen attenuates cue-induced reinstatement of alcohol-seeking behavior in Sardinian alcohol-preferring (sP) rats. Drug Alcohol Depend 2008;95:284-7.
43. B receptors in the rat central nervous system. J Comp Neurol 1999;405:299-321.
44. Markou A, Weiss F, Gold LH, Caine SB, Schulteis G, Koob GF. Animal models of drug craving. Psychopharmacology 1993;112:163-82.
45. McBride WJ, Li TK. Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol 1998;12:339-69.
46. McBride WJ, Le AD, Noronha A. Central nervous system mechanisms in alcohol relapse. Alcohol Clin Exp Res 2002;26:280-6.
47. Moore EM, Boehm II SL. Site-specific microinjection of baclofen into the anterior ventral tegmental area reduces binge-like ethanol intake in male C57BL/6J mice. Behav Neurosci 2009;123:555-63.
48. Moore EM, Serio KM, Goldfarb KJ, Stepanovska S, Linsenbardt DN, Boehm Jr SL. GABAergic modulation of binge-like ethanol intake in C57BL/6J mice. Pharmacol Biochem Behav 2007;88:105-13.
49. Morishita R, Kato K, Asano T. GABAB receptors couple to G proteins Go, G*o and Gi1 but not to Gi2. FEBS Lett 1990;271:231-5.
50. Murphy JM, Gatto GJ, Waller MB, McBride WJ, Lumeng L, Li TK. Effects of scheduled access on ethanol intake by the alcohol-preferring (P) line of rats. Alcohol 1986;3:331-6.
51. Murphy JM, Stewart RB, Bell RL, Badia-Elder NE, Carr LG, McBride WJ, et al. Phenotypic and genotypic characterization of the Indiana University rat lines selectively bred for high and low alcohol preference. Behav Genet 2002;32:363-88.
52. Muzyk AJ, Rivelli SK, Gagliardi JP. Defining the role of baclofen for the treatment of alcohol dependence: a systematic review of the evidence. CNS Drugs 2012;26(1): 69-78.
53. Petry NM. Benzodiazepine-GABA modulation of concurrent ethanol and sucrose reinforcement in the rat. Exp Clin Psychopharmacol 1997;5:183-94.
54. B2 receptor protein in cerebral cortex and thalamus of adult rats. Neuroreport 2001;12:591-5.
55. Ribeiro AF, Pigatto G, Goeldner FO, Lopes JF, Lacerda RB. Lack of relation between drug-seeking behavior in an addiction model and the expression of behavioral sensitization in response to ethanol challenge in mice. J Neural Transm 2008;115:43-54.
56. Ribeiro AF, Correia D, Chiavegatto S, Boerngen-Lacerda R, Brunialti-Godard AL. The Gabbr1 and Gabbr2 genes are involved with addictive behavior: a study in different phenotypes of ethanol consumers. Alcohol Clin Exp Res 2010;34(Suppl. 2):39A.
57. Ribeiro AF, Correia D, Torre AA, Villas Boas GR, Rueda AVL, Camarini R, et al. A transcriptional study in mice with different ethanol-drinking profiles: possible involvement of the GABAB receptor. Pharmacol Biochem Behav 2012;102(2): 224-32.
58. Sanchis-Segura C, Spanagel R. Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol 2006;11:2-38.
59. Shoaib M, Swanner LS, Beyer CE, Goldberg SR, Schindler CW. The GABA-B agonist baclofen modifies cocaine self-administration in rats. Behav Pharmacol 1998;9: 195-206.
60. Sinclair JD, Senter RJ. Increased preference for ethanol in rats following alcohol deprivation. Psychon Sci 1967;8:11-2.
61. Smith BR, Robidoux J, Amit Z. GABAergic involvement in the acquisition of voluntary ethanol intake in laboratory rats. Alcohol Alcohol 1992;27:227-31.
62. B agonist baclofen on the temporal and structural characteristics of ethanol intake. Alcohol 1999;17:231-40.
63. Spanagel R. Alcohol addiction research: from animal models to clinics. Best Pract Res Clin Gastroenterol 2003;17:507-18.
64. Tanchuck MA, Yoneyama N, Ford MM, Fretwell AM, Finn DA. Assessment of GABA-B, metabotropic glutamate, and opioid receptor involvement in an animal model of binge drinking. Alcohol 2011;45:33-44.
65. Tsuji M, Nakagawa Y, Ishibashi Y, Yoshii T, Takashima T, Shimada M, et al. Activation of ventral tegmental GABAB receptors inhibits morphine-induced place preference in rats. Eur J Pharmacol 1996;313:169-73.
66. Walker BM, Koob GF. The γ-aminobutyric acid-B receptor agonist baclofen attenuates operant responding for ethanol in ethanol-dependant rats. Alcohol Clin Exp Res 2007;31:11-8.
67. Whitney G, Harder DB. Genetics of bitter perception in mice. Physiol Behav 1994;56: 1141-7.
68. Wolffgramm J, Galli G, Thimm F, Heyne A. Animal models of addiction: models for therapeutic strategies? J Neural Transm 2000;107:649-68.
69. Woodward DJ, Chang JY, Janak P, Azarov A, Anstrom K. Mesolimbic neuronal activity across behavioral states. Ann N Y Acad Sci 1999;877:91-112.
70. B receptors play a role in the development of tolerance to ethanol in mice. Psychopharmacology 2001;153: 415-24.